Is GBL legal in Austria?

Legal status

Controlled in Austria under the new psychoactive substances regime, and not as a narcotic or a psychotrope. The placement is Annex I of the NPS regulation's structural annexes: the narcotics instrument expressly excludes butyrolactone from its Annex IV.1 ester extension by footnote, and the new psychoactive substances regulation then names Butyro-1,4-lacton in its Annex I. GBL is therefore excluded from one instrument by name and included in another by name, which is a deliberate placement rather than a gap. Being on the NPS list means the offence is the NPSG §4 supply offence with its intent elements, not simple possession. The new psychoactive substances regime works by generic definition. NPSG §3(2) permits chemical substance classes to be defined, NPSV §1(1) takes in Annex I by name and Annex II by structure, and Annex III's illustrations are examples rather than an exhaustive set. NPSG §1 requires psychoactivity and synthetic manufacture, and §2 removes lawful medicinal channels and SMG controlled substances from scope, so the structural fit is necessary and not sufficient.

Consequences if caught

Capital exposure: none. Ten years under NPSG §4(2) is the top of this route, available only on the fatal or gravely injurious consequence limb, and neither a life sentence nor a capital one exists anywhere in the NPS Act or in Austrian law. GBL is the row where an express exclusion from the narcotics instrument is what fixes the ceiling, because without that footnote the GHB ester extension would have reached it. The base offence in NPSG §4(1) allows two years, and it is emphatically not a possession offence: it requires an intention to obtain an advantage, the production, import, export, transfer or procurement conduct, and the intent that the other person or a third party use the substance to achieve a psychoactive effect in the human body. Mere possession is absent from it. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. This row is placed outside that regime, so they are recorded as Austria's published drug penalties and not as this substance's exposure.

If prescribed or medical

The rule that governs every traveller in Austria is SMG §5(1). It confines the acquisition, possession, production, processing, carriage, import, export, offering, transfer and procurement of a Suchtmittel to medical, dental, veterinary and scientific purposes, and the particular travel, licensing and dispensing provisions operate inside it rather than around it. Because this substance is reached by the new psychoactive substances regime rather than by the narcotics or psychotrope lists, neither the SMG §30(3) medicine exception nor the psychotrope travel certificate applies to it. NPSG §2 excludes lawful medicinal channels from that regime, which is a carve out for products that already hold a medicinal authorisation and not a route a traveller can claim for themselves. GBL has industrial uses rather than medicinal ones, and NPSG §5 allows confiscation unless the lawful purpose exception is satisfied.

Documentation

Carry the analysis rather than the label, since NPSG §4(1) reaches supply conduct with an advantage intent and it is the identification of the compound that puts it inside or outside the annex. GBL is excluded from the narcotics ester clause by an express footnote and named on the NPS list instead. The NPS structural annexes were read at their 18 September 2026 consolidation, with Annexes II and III last amended by BGBl II 106/2024 of 18 April 2024 and Annex I last amended by BGBl II 168/2019.

Drug laws and enforcement change and vary within a country. This is not legal advice. Always confirm with Austria’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.